Mirtazapine treatment and sexual functions: Results of a Hungarian, multicentre, prospective study in depressed out-patients

Peter Osváth, Sandor Fekete, Viktor Vörös, Janos Almási

Research output: Contribution to journalArticle

1 Citation (Scopus)


Since many antidepressants can cause sexual dysfunction, the aim of this study was to follow-up sexual functions during mirtazapine (RemeronSolTab®) treatment. One hundred and two (44 male and 58 female) outpatients with major depression were recruited to this prospective, observational, non-interventional study. The screening was followed by three visits, during which the 17-HAMD, CGI and 9-BDI scales were used. The change of sexual life was monitored by a self-completing questionnaire, based on the modified Psychotropic-Related Sexual Dysfunction Questionnaire. During the treatment both the depression rating scales and the CGI have shown a significant improvement and significant amelioration of previous sexual problems was found; patients were evaluating their sexual life better and better. Our results indicated that mirtazapine is an effective tool for depressed patients who suffer from sexual dysfunction.

Original languageEnglish
Pages (from-to)242-245
Number of pages4
JournalInternational Journal of Psychiatry in Clinical Practice
Issue number3
Publication statusPublished - Sep 27 2007



  • Depression
  • Mirtazapine (Remeron SolTab®)
  • Prospective study
  • Sexual dysfunction

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this